Radiation-Free Screening Can ID Interstitial Lung Involvement in RA
FRIDAY, Dec. 6, 2024 -- For asymptomatic rheumatoid arthritis (RA) patients, a new radiation-free screening protocol can identify suspected interstitial lung involvement (ILI), according to a study published online Nov. 23 in BMC Pulmonary Medicine.
Frank Reichenberger, M.D., from Augustinum Hospital Munich, and colleagues proposed a noninvasive, radiation-free approach to ILI screening using pulmonary function tests (PFT) and pleuro-pulmonary transthoracic ultrasound (LUS) with additional cardiopulmonary exercise tests with electrocardiography and echocardiography. The study included 67 consecutive patients with a confirmed diagnosis of seropositive RA, without symptoms for or known cardiovascular disease. When significant LUS abnormalities and additional PFT changes were present, interstitial lung disease (ILD) was suspected.
The researchers found that 40 percent of patients had noticeable changes in LUS, 24 percent with a pattern compatible with ILD. LUS abnormalities and additional PFT changes were present in 16 percent of cases, and ILI was suspected. Obstructive lung disease; subpleural consolidation, including one confirmed lung cancer; minimal pleural effusion; and ischemic cardiac disease were included as additional findings (11, six, six, and two patients, respectively). Pulmonary vascular involvement was not seen in any of the patients.
"Our study supports the growing evidence and experience in using LUS for screening for RA-ILD," the authors write. "We propose LUS as an appropriate imaging tool in combination with PFT for ILD screening in RA."
The study was funded by Boehringer Ingelheim.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.